<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589936/" ref="ordinalpos=1019&amp;ncbi_uid=4682619&amp;link_uid=PMC3589936" image-link="/pmc/articles/PMC3589936/figure/RRS098F2/" class="imagepopup">Fig. 2. From: Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist. </a></div><br /><div class="p4l_captionBody">PEI is a novel TLR5 agonist that activates the NF-κB intracellular signaling pathway mediated by TLR5. (<b>A</b>) The cytotoxicity of PEI was measured by MTT assay. There was no significant cytotoxicity when PEI concentration was below 0.5 μmol/l. (<b>B</b>) PEI is a novel TLR5 agonist that activates the TLR5-mediated NF-κB intracellular signaling pathway. Dual-luciferase reporter gene expression, showing PEI (0.2–1.0 μmol/l) can activate the TLR5-mediated NF-κB intracellular signaling pathway. *P&lt; 0.05, vs. control.</div></div>